Shareholding2 Jul 2026, 08:18 am
CTL Trusteeship Discloses Indirect Encumbrance on Gujarat Themis Biosyn Shares
AI Summary
CTL Trusteeship Limited, acting as a debenture trustee, has filed a disclosure under SEBI's Takeover Code regarding an indirect encumbrance on shares of Gujarat Themis Biosyn Limited. This arises from encumbrances placed by Vividhmargi Investments Private Limited (VIPL) on shares of Pharmaceutical Business Group (India) Limited (PBGIL), which in turn holds a significant stake in Gujarat Themis Biosyn. Specifically, VIPL has pledged 51% and placed a non-disposal undertaking on 47.988% of PBGIL's shares. The disclosure clarifies that no direct acquisition of Gujarat Themis Biosyn shares has occurred, but the encumbrances may lead to an indirect control situation.
Key Highlights
- CTL Trusteeship discloses indirect encumbrance on Gujarat Themis Biosyn shares.
- Encumbrance stems from VIPL's actions on PBGIL shares.
- Pledge and non-disposal undertaking created on PBGIL shares.
- No direct acquisition of target company shares at present.
- Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Price Impact
More from GUJTHEM